Figure 2From: Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulationsDevelopment of anti-GMZ2, anti-GLURP and anti-MSP3 total IgG responses in three mouse strains upon immunization with differentially-formulated GMZ2. Shown are ELISA mean endpoint titres (+ S. D.) of individual immunization groups.Back to article page